AFP and hepatocellular carcinoma: It can help distinguish alpha-fetoprotein (AFP)-negative HCC from benign nodules, suggesting that GPC3 is a more reliable biomarker than AFP in diagnosing HCC (Llovet et al., 2006; Wang et al., 2006).